tradingkey.logo
tradingkey.logo
Search

SANUWAVE Health Inc

SNWV
Add to Watchlist
4.550USD
+0.420+10.17%
Close 09-18 16:00ET
38.93MMarket Cap
2.35P/E TTM

More Details of SANUWAVE Health Inc Company

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.

SANUWAVE Health Inc Profile

Ticker SymbolSNWV
Company nameSANUWAVE Health Inc
IPO dateNov 07, 2008
CEOFrank (Morgan C)
Number of employees46
Security typeOrdinary Share
Fiscal year-endNov 07
Address9600 W. 6Th Sstreet
CityEDEN PRAIRIE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code55344
Phone19526561029
Websitehttps://sanuwave.com/
Ticker SymbolSNWV
IPO dateNov 07, 2008
CEOFrank (Morgan C)

Company Executives of SANUWAVE Health Inc

Name
Name/Position
Position
Shareholding
Change
Mr. James (Jim) Tyler
Mr. James (Jim) Tyler
Independent Director
Independent Director
8.70K
--
Mr. James (Jim) Tyler
Mr. James (Jim) Tyler
Independent Director
Independent Director
8.70K
--
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
--
Mr. David Timothy (Tim) Wern
Mr. David Timothy (Tim) Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
469.00
--
Mr. David Timothy (Tim) Wern
Mr. David Timothy (Tim) Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
469.00
--
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
--
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
--
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
--
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
Independent Director
Independent Director
--
-100.00%
Mr. Ian Miller
Mr. Ian Miller
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. James (Jim) Tyler
Mr. James (Jim) Tyler
Independent Director
Independent Director
8.70K
--
Mr. James (Jim) Tyler
Mr. James (Jim) Tyler
Independent Director
Independent Director
8.70K
--
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
--
Mr. David Timothy (Tim) Wern
Mr. David Timothy (Tim) Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
469.00
--
Mr. David Timothy (Tim) Wern
Mr. David Timothy (Tim) Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
469.00
--
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
--

FAQs

Who are the top five shareholders of SANUWAVE Health Inc?

The top five shareholders of SANUWAVE Health Inc are: Mr. James (Jim) Tyler

How many institutions hold shares of SANUWAVE Health Inc (SNWV)?

As of 2026Q1, 125 institutions hold shares of SANUWAVE Health Inc, with a combined market value of approximately 5.44M, accounting for 63.34% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 562828.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.